Comparison of long-term (4-year) outcomes of patients with unprotected left main coronary artery narrowing treated with drug-eluting stents versus coronary-artery bypass grafting.

Wu X, Chen Y, Liu H, Teirstein PS, Kirtane AJ, Ge C, Song X, Chen X, Gu C, Huang F, Lv S

A novel technique for ultra-low contrast administration during angiography or intervention.

Nayak KR, Mehta HS, Price MJ, Russo RJ, Stinis CT, Moses JW, Mehran R, Leon MB, Kandzari DE, Teirstein PS

Longer-term outcomes of paclitaxel stent implantation as an initial treatment strategy for sirolimus-eluting stent restenosis.

Levisay JP, Price MJ, Shaba W, Lee SS, Stinis CP, Miller L, Teirstein PS

Dual catheter technique for the treatment of severe coronary artery perforations.

Ben-Gal Y, Weisz G, Collins MB, Genereux P, Dangas GD, Teirstein PS, Singh VP, Rabbani LE, Kodali SK, Sherman W, Leon MB, Moses JW

Three-year outcome of drug-eluting stent implantation for coronary artery bifurcation lesions.

Stinis CT, Hu SP, Price MJ, Teirstein PS

Identifying the "optimal" duration of dual antiplatelet therapy after drug-eluting stent revascularization.

Kandzari DE, Angiolillo DJ, Price MJ, Teirstein PS

Revascularization for unprotected left main disease: evolution of the evidence basis to redefine treatment standards.

Kandzari DE, Colombo A, Park SJ, Tommaso CL, Ellis SG, Guzman LA, Teirstein PS, Tamburino C, Ormiston J, Stone GW, Dangas GD, Popma JJ, Bass TA, American College of Cardiology Interventional Scientific Council

Percutaneous left atrial appendage occlusion for patients in atrial fibrillation suboptimal for warfarin therapy: 5-year results of the PLAATO (Percutaneous Left Atrial Appendage Transcatheter Occlusion) Study.

Block PC, Burstein S, Casale PN, Kramer PH, Teirstein P, Williams DO, Reisman M

Predictors of heightened platelet reactivity despite dual-antiplatelet therapy in patients undergoing percutaneous coronary intervention.

Price MJ, Nayak KR, Barker CM, Kandzari DE, Teirstein PS

Ionic low-osmolar versus nonionic iso-osmolar contrast media to obviate worsening nephropathy after angioplasty in chronic renal failure patients: the ICON (Ionic versus non-ionic Contrast to Obviate worsening Nephropathy after angioplasty in chronic renal failure patients) study.

Mehran R, Nikolsky E, Kirtane AJ, Caixeta A, Wong SC, Teirstein PS, Downey WE, Batchelor WB, Casterella PJ, Kim YH, Fahy M, Dangas GD